Greg N. Fuller

Professor
The University of Texas MD Anderson

Disclosure: Nothing to disclose

Presentation(s):

• INNV-40 - Targeted Next Generation Sequencing of Pediatric High-Grade Glioma and Its Therapeutic Implications, MD Anderson Experience

  Friday, November 22
  7:30 PM – 9:30 PM

• PDCT-02 - Unique concurrent association of somatic and germline NF1 mutations with germline mismatch repair mutations in pediatric glioblastoma multiforme

  Friday, November 22
  7:30 PM – 9:30 PM

• PDCT-16 - A phase I study of Suberoylanilide Hydroxamic Acid (SAHA) with Temsirolimus in children with newly diagnosed or progressive diffuse intrinsic pontine glioma (DIPG)

  Friday, November 22
  7:30 PM – 9:30 PM

• TMIC-60 - Comprehensive spatial characterization of immune cells in the CNS brain tumor microenvironment

  Friday, November 22
  8:18 PM – 8:22 PM

• RARE-47 - Characterization of Adult Medulloblastoma; a retrospective review of 200 patients at MD Anderson Cancer Center

  Saturday, November 23
  5:00 PM – 7:00 PM